2006
DOI: 10.1002/art.21811
|View full text |Cite
|
Sign up to set email alerts
|

Vascular endothelial growth factor gene haplotypes in Kawasaki disease

Abstract: ObjectiveTo investigate whether common genetic variants in the vascular endothelial growth factor (VEGF) gene are associated with Kawasaki disease (KD) and the subsequent development of coronary artery lesions.MethodsCommon genetic variants in the VEGF gene were analyzed in an association study in a Dutch cohort of 170 KD patients and 300 healthy Dutch Caucasian controls. Genotyping was done with 5′‐nuclease TaqMan assays and 3′‐hybridization–triggered fluorescence minor groove binder Eclipse assays.ResultsAn … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
29
2
1

Year Published

2006
2006
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(33 citation statements)
references
References 36 publications
1
29
2
1
Order By: Relevance
“…Polymorphisms in the VEGF gene have also been identified with some of them leading to altered activity [1,8,26]. However, the role of VEGF gene variants in the development of late adverse events after radiotherapy is still unclear.…”
Section: Introductionmentioning
confidence: 99%
“…Polymorphisms in the VEGF gene have also been identified with some of them leading to altered activity [1,8,26]. However, the role of VEGF gene variants in the development of late adverse events after radiotherapy is still unclear.…”
Section: Introductionmentioning
confidence: 99%
“…30 Although several other groups have studied other combinations of HLA subtypes, no consistent association has been detected so far. Considering that no significant linkage was detected near the 6p region in our genome-wide linkage analysis, 31 34 and MCP-1 35 ), hematopoietins (interleukin-4 (IL-4) [36][37][38] and IL-6 39 ), IL-1 family (IL-1b, 37 IL-18, 40 and IL-1Ra 37 ), IL-10 family (IL-10 41 ), platelet-derived growth factor family (vascular endothelial growth factor (VEGF) [42][43][44][45] and VEGFR2 42 ), and tumor necrosis factor (TNF) family (TNF-a, 46-50 lipoteichoic acid, 47 and CD40L 51,52 ). Other candidates include plasma proteins (C-reactive protein [53][54][55] and MBL2 53,55,56 ), matrix metalloproteinase (MMP) and their inhibitors (MMP2, 58 MMP3, 57,58 MMP-9, 58 MMP-12, 58 MMP-13, 58 and tissue inhibitors of metalloproteinase-2 59 ), enzymes related to atherosclerosis (methylenetetrahydrofolate reductase (MTHFR), 60 endothelial nitric oxide synthase, 61 and inducible nitric oxide synthase 61 ), components of the renin-angiotensin system (angiotensin-converting enzyme [62][63][64][65] and AGTR1 64 ), and an unclassified group (CD14, 66 FCGR2A, 67,68 SLC11A1, 69 PLA2G7, 70 UGT1A1, 71 MICA, 72 and HMOX1 71 ).…”
Section: Candidate Gene Approachmentioning
confidence: 78%
“…Kariyazono et al 30 and Breunis et al 31 reported that the vascular endothelial growth factor gene polymorphism was associated with susceptibility and CAL formation in KD; however, it cannot be verified in the Taiwanese population. 32 Burns et al 33 revealed that interleukin 4 has an important role in KD pathogenesis and disease susceptibility, but the results are different from the studies in the Taiwanese population.…”
Section: Discussionmentioning
confidence: 99%